Livzon Pharmaceutical Group Inc. (HKG:1513)

Hong Kong · Delayed Price · Currency is HKD

28.40

+1.08 (3.95%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2018	FY 2018	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022	Jan '21 Jan 1, 2021	Jan '20 Jan 1, 2020	Dec '18 Dec 31, 2018	Jan '18 Jan 1, 2018	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceutical Manufacturing	11.81B	12.43B	12.63B	12.06B	10.52B
Pharmaceutical Manufacturing Growth	-4.97%	-1.58%	4.69%	14.67%	12.10%
Total	11.81B	12.43B	12.63B	12.06B	10.52B
Total Growth	-4.97%	-1.58%	4.69%	14.67%	12.10%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2018	FY 2018	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022	Jan '21 Jan 1, 2021	Jan '20 Jan 1, 2020	Dec '18 Dec 31, 2018	Jan '18 Jan 1, 2018	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	9.98B	10.75B	10.96B	10.39B	8.74B
China Growth	-7.23%	-1.86%	5.48%	18.90%	8.10%
Overseas	1.72B	1.57B	1.57B	1.54B	1.73B
Overseas Growth	9.69%	0.40%	1.72%	-10.82%	39.84%
Total	11.70B	12.33B	12.52B	11.93B	10.46B
Total Growth	-5.07%	-1.58%	4.99%	14.00%	12.30%

Source: S&P Global Market Intelligence.